Electroconvulsive therapy use in adolescents: a systematic review by Lima, Nádia Nara Rolim et al.
  Universidade de São Paulo
 
2013
 
Electroconvulsive therapy use in adolescents:
a systematic review
 
 
Annals of General Psychiatry, London, v.12, n.17, p.1-9, 2013
http://www.producao.usp.br/handle/BDPI/34854
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Saúde Materno Infantil - FSP/HSM Artigos e Materiais de Revistas Científicas - FSP/HSM
REVIEW Open Access
Electroconvulsive therapy use in adolescents:
a systematic review
Nádia NR Lima1, Vânia B Nascimento1, Jorge AC Peixoto1, Marcial M Moreira1, Modesto LR Neto2*,
José C Almeida3, Carlos AC Vasconcelos4, Saulo A Teixeira5, Jucier G Júnior5, Francisco TC Junior5,
Diego DM Guimarães5, Aline Q Brasil5, Jesus S Cartaxo1, Marco Akerman1 and Alberto OA Reis6
Abstract
Background: Considered as a moment of psychological vulnerability, adolescence is remarkably a risky period for
the development of psychopathologies, when the choice of the correct therapeutic approach is crucial for
achieving remission. One of the researched therapies in this case is electroconvulsive therapy (ECT). The present
study reviews the recent and classical aspects regarding ECT use in adolescents.
Methods: Systematic review, performed in November 2012, conformed to the PRISMA statement.
Results: From the 212 retrieved articles, only 39 were included in the final sample. The reviewed studies bring
indications of ECT use in adolescents, evaluate the efficiency of this therapy regarding remission, and explore the
potential risks and complications of the procedure.
Conclusions: ECT use in adolescents is considered a highly efficient option for treating several psychiatric disorders,
achieving high remission rates, and presenting few and relatively benign adverse effects. Risks can be mitigated by
the correct use of the technique and are considered minimal when compared to the efficiency of ECT in treating
psychopathologies.
Background
Adolescence is a period of deep emotional and physical
changes. This moment of psychological vulnerability fa-
vors the development of serious and potentially dam-
aging psychopathologies [1]. Adolescents present higher
rates of self-destruction impulses and are more com-
monly refractory to traditional medications. In addition,
major depression affects near 8% of adolescents, more
commonly during puberty. Forty percent of them
present recurrent attacks, and a third will experience at
least one suicide attempt [2]. In these cases, the choice
of the correct therapeutic modalities is crucial for
achieving the remission of symptoms.
The introduction of electroconvulsive therapy (ECT)
for the treatment of serious mental disturbs, such as
major depression and bipolar disorder, was one of most
impacting revolutions of psychiatry. Convulsive therapy
was introduced to psychiatric practice in 1934, by
Hungarian neuropsychiatrist László Meduna [3]. In his
autobiography [4], Meduna described L. Zoltán's case,
his first patient subjected to convulsive therapy [3,4]. L.
Zoltán had a 4-year condition of catatonic schizophrenia
that was considered hopeless but after having received
several sessions of camphor-induced convulsive therapy
[4,5], achieved full remission [3]. Later on, in 1938, Bini
and Cerletti reported the first electroconvulsive proced-
ure, suggesting the use of electricity after observing the
clinical success and difficulties of seizure inductions with
metrazol [6].
Due to controversies regarding its effectiveness and
safety, for a long time, ECT had a bad reputation and
was considered untrustworthy. Only in the 1970s, the
American Task Force Report on ECT proved the effect-
iveness of ECT use, especially in the depressed phase of
bipolar disorder and the ‘involutional melancholia’ [7].
Brazilian Federal Council of Medicine, in its Reso-
lution n. 1640, published in July 2002, regulates the use
of electroconvulsive therapy in Brazil. Still, it prohibited
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the use of ECT in patients below 16 years of age, unless
in exceptional circumstances [8].
Along these lines, a key question addressed by this
study is whether ECT is useful for therapeutic purposes
in adolescents. Taking this into consideration, this study
aimed at reviewing the recent and classical aspects re-
garding electroconvulsive therapy and its application for
adolescents; we performed a detailed, systematic review
of medical literature, of which resulted in this article.
Methods
We performed, in November 2012, a qualitative system-
atic review of articles about the role of electroconvulsive
therapy use in adolescents published in previously
chosen electronic databases. The qualitative approach
was chosen because quantitative methods, such as meta-
analysis, show that (a) the necessary information in
order to calculate result size is not available and may
limit this analysis to a small subset of studies and (b) age
intervals regarding adolescence vary greatly among stud-
ies included in the sample, making it difficult to ad-
equately compare and to do the proper statistical
analysis.
The methods used to identify, select and appraise rele-
vant research, and to collect and analyze data from the
studies we reviewed were in agreement with the
PRISMA protocol for systematic reviews and meta-
analyses [9]. According to The Cochrane Collaboration,
which published the PRISMA guidelines, reporting med-
ical research in systematic reviews must be based in in-
formation that composes the acronym ‘PICOS’ (patient,
intervention, comparator, outcome, study design). For
this article, ‘P’ represented adolescents, ‘I’ was electrocon-
vulsive therapy, ‘C’ was absent or only-pharmacological
therapy, ‘O’ was symptoms remission and ‘S’ was case re-
ports, series of cases, literature reviews, cross-sectional
studies, exploratory field research and prospective/retro-
spective cohorts.
In order to set a parameter for limiting the age group
covered by the present review, the definition of ‘adoles-
cence’ adopted in this study was from Medical Subject
Headings MeSH), the National Library of Medicine's
controlled vocabulary thesaurus used for indexing arti-
cles for PubMed. Thus, when used in this study, the
term ‘adolescent’ refers to a person from 13 to 18 years
of age and consequently, the term ‘adolescence’ refers to
the state or time of being 13 to 18 years of age.
Then, each paper in the sample was read entirely, and
data elements were then extracted and entered into a
matrix that included authors, publication year, descrip-
tion of the study sample and main findings, as well as a
matrix that included the PICOS acronym of the selected
articles. Some of the studies dealt not only with ECT use
in adolescents but also in children and adults; because
the focus of this study was on ECT use in adolescents,
children- or adult-related results were not recorded or
analyzed for this study.
Finally, so as to provide a better analysis, the next
phase involved grouping, for heuristic reasons, results
regarding the studied subject in four themes: (1) indica-
tions for ECT use in adolescents; (2) electroconvulsive
therapy - treatment parameters; (3) efficiency of ECT,
associations with other therapies and comparison be-
tween techniques; and (4) side effects, risks, and compli-
cations of ECT for adolescents.
Literature review
Three medical databases were surveyed: PMC (United
States National Library of Medicine), LILACS (Literatura
Latino-Americana e do Caribe em Ciências da Saúde),
and SciELO (Scientific Electronic Library Online). The
keywords used in all searches were all valid MeSH
(NLM/NIH) terms: ‘electroconvulsive therapy’, ‘electro-
shock’, ‘ECT’, ‘adolescence’, ‘adolescent’, ‘treatment’, ‘depres-
sion’, ‘schizophrenia’, and ‘bipolar disorder’.
Eligibility criteria
Selected articles were according to the following inclu-
sion criteria: (1) manuscripts written in English, Portu-
guese, Spanish, or French; (2) case reports, series of
cases, case-controls, literature reviews, cross-sectional
studies, exploratory field research, and prospective and
retrospective cohort studies; (3) studies regarding the
use of electroconvulsive therapy in adolescents, provided
they attended at least three of the five previously men-
tioned PICOS criteria: adolescent, ECT, absent or only
drugs, symptoms remission, and study design. Studies
assessing other conditions, editorials, and letters to the
editor were excluded.
Results
Initially, the aforementioned search strategies resulted in
212 references. After assessing the title and abstract of
the retrieved citations for eligibility based on the inclu-
sion criteria, 139 articles were excluded after applying
criteria 1 and 2, and 40 manuscripts were excluded after
applying criterion 3.
At this moment, six additional articles were included
in the sample [2-5,9,10], identified through the reference
lists of the previously retrieved articles and considering
their importance to the field of study. Finally, 39 articles
were further selected and included in the final sample
(Figure 1).
Table 1 provides an overview of all studies included in
the final sample, synthesizing the studies' characteristics,
with reference to participants, interventions, compari-
sons, outcomes, and study design (PICOS), according to
PRISMA statement.
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Discussion
The present study reviewed 39 articles that dealt with
different aspects of the use of ECT and its application in
adolescents. Table 2 summarizes the main findings re-
garding the use of ECT in adolescents, grouped in three
different sections. We now proceed to analyze the main
findings of the retrieved studies.
Indications for ECT use in adolescents
Although information on the subject is scarce [29], indi-
cations for ECT use in adolescents cover a wide range of
psychological diseases. The American Academy of Child
and Adolescent Psychiatry (AACAP) has issued a guide-
line titled ‘Practice Parameter For Use of Electrocon-
vulsive Therapy With Adolescents,’ establishing that
eligibility for ECT in adolescents involves meeting three
criteria, as follows: (1) diagnosis, (2) severity of symp-
toms, and (3) lack of treatment response to appropriate
psychopharmacological agents accompanied by other ap-
propriate treatment modalities [27]. Regarding diagnosis,
ECT use is recommended for adolescents with serious
psychiatric disorders, such as persistent major depres-
sion, schizoaffective disorder, schizophrenia, or history
of manic episodes, with or without psychotic features
[19]. Other studies point out that ECT can be used in
this population also to treat catatonia and neuroleptic
malignant syndrome [26,30]. Still according to AACAP's
guideline, patient's symptoms must be severe, persistent,
and significantly disabling, what can include life-
threatening symptoms, such as refusal to drink or eat,
uncontrollable mania, florid psychosis, and severe sui-
cide intentions [27]. The lack of treatment response -
when considered at least two adequate trials of correct
drugs, in association with other therapeutic modalities -
is also one of the three criteria, and the fulfillment of
this criterion may require patient's observation in a hos-
pital setting [20].
Electroconvulsive therapy may be considered earlier in
cases when psychopharmacological treatment is not tol-
erated by the patient, when adolescent is significantly in-
capacitated, not being able to take medication, or when
waiting for response of psychopharmacological treat-
ment may put the patient's life at risk [17,27].
After conducting a thorough medical evaluation, the
psychiatrist decides whether the patient is to be treated
with ECT. The severity of illness must be evaluated with
extra care by a detailed patient interview, as well as by
gathering information from parents or caregivers and by
the use of a reliable symptom assessment scale [38]. It is
also important to know about previous pharmacological
treatment (asking about drugs, dosage, duration, compli-
ance, response, and side effects). In some cases, compli-
ance rate evaluation requires measuring urine and
serum drug levels. Psychotherapeutic approaches (indi-
vidual, interpersonal, or cognitive-behavioral therapies)
experienced by the patient should also be recorded in
the patient's medical chart.
Despite being as effective in adolescents as it is in
adults [29], ECT is much less frequently used in adoles-
cents. Three of the retrieved studies compared ECT use
in adolescents with ECT use in patients of other ages.
Adolescents subjected to ECT accounted for only 0.43%
of the total in India, 0.93% in Australia, and 1.5% in the
USA [32,33,36].
Figure 1 Flow chart showing study selection for the review.
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Table 1 Characteristics (PICOS) of the articles included in the review
Author
(publication year)
Patient Intervention Comparator Outcome Study design
Gedge et al. [11] (2012) Age 18 or older ECT and rTMS Absent Serum BDNF may not be a
biomarker of ECT or rTMS
treatment response
Prospective cohort
Garg et al. [12] (2011) Age 16 to 65 ECT Absent Yes Prospective cohort
Rolim-neto et al. [2]
(2011)
Children and
adolescents
- Absent Child depression Literature review
Shoirah and Hamoda
[13] (2011)
Adolescents ECT Absent - Literature review
Wachtel et al. [6] (2011) Children and
adolescents
ECT Absent Efficacy rate of 63% for depression Literature review
Baeza et al. [7] (2010) Age 13 to 17 Evaluation before,
after and 6 months
after ECT
Absent ECT is safe and effective treatment
for SSD
Retrospective
cohort
Consoli et al. [14] (2010) Children and
adolescents
ECT Absent - Literature review
Antunes et al. [15]
(2009)
- ECT Absent 50 to 80% Literature review
Hazell [1] (2009) Children and
adolescents
Various Absent No article about ECT met the
including criteria
Systematic review
Moher et al. [9] (2009) - - - PRISMA statement Review
Baghai and Moller
[16] (2008)
- ECT Absent ECT is treatment proven to be a
highly effective treatment
option depression
Literature review
Feliu et al. [17] (2008) Age 19 to 96 ECT Absent Yes Series of cases
Lévy-Rueff et al. [18]
(2008)
Age 30 to 67 ECT Absent Moderate efficacy of M-ECT on
schizophrenia
Retrospective
cohort
Arshad et al. [19] (2007) Age 16 and above Questionnaire
about ECT
Absent Low acceptability of ECT Cross-sectional
study
Blaj et al. [20] (2007) - ECT Absent Questionnaire to psychiatrists Exploratory field
research
Datka et al. [21] (2007) - ECT Only drugs Only temporally affects working
memory function
Prospective cohort
Prakash et al. [22] (2006) Adults ECT Absent Donepezil improves recovery time Triple blind
prospective cohort
Salleh et al. [23] (2006) - ECT Absent Efficacy and safety of ECT on
depression treatment
Literature review
Stein et al. [24] (2006) Children and
adolescents
ECT Absent - Literature review
Zaw [25] (2006) Children and
adolescents
ECT Absent - Literature review
Sienaert et al. [26]
(2005)
Adults and aged ECT Absent ECT patients have memory
complaints, but it is not related
to satisfaction with treatment
Exploratory field
research
Ghaziuddin et al.
[27] (2004)
Adolescents ECT Absent Mood disorders have a high rate
of response (75% to 100%)
Literature review
Segal et al. [28] (2004) Age 13 ECT Absent Full symptom resolution Case report
Bloch et al. [29] (2001) Age 13 to 19 ECT Absent 58% remission Retrospective
cohort
Daly et al. [30] (2001) Average group
age of 58.5 and
55.8 years old
ECT Absent Yes Prospective cohort
Cohen et al. [31] (2000) Adolescents aged
less than 19 years old
ECT Only drugs Cognitive functions similar to
non-ECT
Retrospective
cohort
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Electroconvulsive therapy treatment parameters
According to the technique of choice, electroconvulsive
therapy may alter its efficacy. The study of Antunes and
colleagues [15] showed that high-dose unilateral ECT
sessions have equivalent efficacy as bifrontotemporal
ECT; on the other hand, low-dose unilateral ECT has
lower efficacy. The same research also brings prelimin-
ary results of studies that suggest that right unilateral
ECT with ultra-brief stimulation, achieved by modern
ECT equipment, preserves the efficacy and substantially
reduces the cognitive side effects.
Another study [27] states that the use of unilateral elec-
trode placement applied to the non-dominant cerebral
hemisphere (usually the right brain in most right-handed
persons) is associated with less memory impairment in the
immediate post-treatment period, recommending bilateral
treatment only if unilateral treatment does not reach an
adequate response.
Still regarding electrode placement, Shoira and
Hamoda [13] state that although bilateral electrode
placement may be more effective than unilateral place-
ment for manic patients, unilateral electrode placement
has been found to have equivalent results for other indi-
cations. However, higher stimulus doses are needed in
unilateral treatment to achieve comparable efficiency.
Unilateral stimulation at six times the seizure threshold
was found to have a remission rate of 55%, compared
with 61% for bifrontal stimulation and to 64% for
bitemporal stimulation at 1.5 times the seizure thresh-
old. When employing ultra-brief stimulation with mod-
ern ECT equipment, unilateral electrode placement at
six times the seizure threshold has even been reported
to be more effective than bilateral placement at 1.5 times
the seizure threshold.
Summing up, it can be speculated that the best tech-
nique of ECT is unilateral, over the non-dominant cere-
bral hemisphere, using modern equipment capable of
brief or ultra-brief stimulation. A study with a quantita-
tive approach, comparing the efficacy and side effects of
unilateral and bilateral approaches, would be extremely
helpful to patients and procedure guidance.
Baeza and colleagues [7], on a study with a sample of
13 adolescents, used the bifrontotemporal ECT until the
acute symptoms remitted or no further improvement
was shown over three consecutive sessions. Positive re-
sults appeared within 13.9 ± 4.3 ECT sessions, with a
mean duration of electroencephalogram seizures of 43.9 ±
16.9 s (range, 20 to 93), with significant differences be-
tween males and females. Baghai and Moller [16] state
that the remission rate of psychotic depression approaches
90%, with relief experienced within 10 to 14 days; other
acute psychiatric syndromes such as severe excitement,
e.g., in delirious mania, malignant catatonia, and neuro-
leptic malignant syndrome, may require ECT as a first-
line treatment.
Efficiency of remission, association with other therapies,
and comparison between techniques
Several trials have investigated remission as a parameter
of efficiency of ECT use in adolescents. A study compar-
ing patients who accepted ECT with those who refused
this treatment showed that the first group improved sig-
nificantly compared to the second [19]. The patients
treated with ECT also had a shorter mean duration of
hospital stay (73.8 vs. 176 days) [27]. In ten adolescents
with primary, endogenous, psychotic depression who
were resistant to antidepressant pharmacotherapy, ECT
resulted in 60% of complete remission and 40% of partial
remission after 1 month post-ECT [10].
In a cohort study with a sample that included adoles-
cents, remission rates after treatment with ECT was
equal for both adolescents and adults (58% of remis-
sion). The difference between the two studied groups
was that most adolescents had psychotic syndromes,
Table 1 Characteristics (PICOS) of the articles included in the review (Continued)
Ghaziuddin et al.
[32] (1999)
Age 16 ECT Absent Clinical improvement, but
no significant change in
depression score
Case report
Thuppal and Fink
[33] (1999)
Adolescents and adults ECT Absent ECT successful after
pharmacotherapy failure on
mental retardation
Series of cases
Kutcher and Robertson
[34] (1995)
Age 16 to 22 ECT Absent Yes Prospective cohort
Calev [35] (1994) - ECT - Trends on ECT treatment Literature review
Parmar [36] (1993) Children and
adolescents, psychiatrists
ECT Absent ECT was less useful in child and
adolescent psychotic depression
Questionnaire
Schneeklot et al.
[37] (1993)
Adolescents ECT Absent ECT reduced or eliminated
symptoms
Retrospective case
review
APA [38] (1990) Various ECT Absent Yes Literature review
Paillère-Martinot et al.
[39] (1990)
Adolescents ECT Absent Yes Comparative study
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Table 2 Electroconvulsive therapy use in adolescents: main findings
Authors Publication
year
Journal Main findings
Indications for ECT use in adolescents
Wachtel et al. [6] 2011 Medical Hypotheses The use of ECT in children and adolescents is appropriate for
specific clinical indications and urge removal of impediments
to ECT access in this population
Baeza et al. [7] 2010 Journal of Child
and Adolescent
Psychopharmacology
ECT is a safe and effective treatment for schizophrenia
spectrum disorders in adolescent patients
Consoli et al. [14] 2010 Journal of ECT Electroconvulsive therapy is the effective treatment for
catatonia after high-dose benzodiazepine trials in youths
Hazell [1] 2009 Clinical Evidence Electroconvulsive therapy is indicated for a severely obtunded
child or adolescent with depression who may, for example, have
prolonged psychotic symptoms, and fails to hydrate or maintain
caloric intake
Baghai and Moller [16] 2008 Dialogues in Clinical
Neuroscience
The safety and tolerability of ECT have been enhanced by the
use of modified stimulation techniques and by the progress of
modern anesthesia, representing a safe treatment that can be offered
to all patients, especially after medication failure
Stein et al. [24] 2006 Child & Adolescent
Psychiatric Clinics of
North America
ECT is an effective therapy for severe and resistant depression,
with relatively minimal adverse effects
Ghaziuddin et al. [27] 2004 Journal of the American
Academy of Child and
Adolescent Psychiatry
Eligible adolescents for ECT must meet three criteria: diagnosis
(severe, persistent major depression or mania, with or without
psychosis, schizoaffective disorder, schizophrenia, and others),
severity of symptoms, and lack of treatment response
Electroconvulsive therapy: treatment parameters
Shoirah and Hamoda [13] 2011 Expert Review of
Neurotherapeutics
Although bilateral electrode placement may be more effective
than unilateral placement for manic patients, unilateral electrode
placement has been found to have equivalent results for
other indications
Baeza et al. [7] 2010 Journal of Child
and Adolescent
Psychopharmacology
The mean duration of electroencephalogram seizures was
43.9 ± 16.9 s (range, 20 to 93), with significant differences
between males and females
Antunes et al. [15] 2009 Revista Brasileira de Psiquiatria Studies show that high-dose unilateral ECT (UL-ECT) has
an equivalent efficacy to bifrontotemporal ECT; however,
low-dose UL-ECT has lower efficacy
Efficiency of ECT, associations with other therapies and comparison between techniques
Garg et al. [12] 2011 Indian Journal of
Medical Research
Patients with treatment-resistant schizophrenia treated
with ECT had an improvement in quality of life. All aspects of
quality of life got better, except the social relations
Lévy-Rueff et al. [18] 2008 Psychiatry Research Part of a clinical cohort was composed by adolescents.
Maintenance ECT in association with pharmacological treatment
presented good outcomes for refractory schizophrenia
Bloch et al. [29] 2001 Journal of the American
Academy of Child and
Adolescent Psychiatry
ECT was equally effective in adolescents and adults (58% of remission),
but most of adolescents presented psychotic syndromes, instead
of affective disorders in adults
Strober et al. [10] 1998 Biological Psychiatry Adolescents aged 13 to 17 years with bipolar depression or major
depressive disorder presented 60% of total and 40% of partial
remission in a month follow-up
Kutcher and Robertson [34] 1995 Journal of Child
and Adolescent
Psychopharmacology
Patients who accepted ECT improved significantly compared to
those who refused. The mean duration of hospital stay was reduced
from 176 to 73.8 days
Schneekloth et al. [37] 1993 Convulsive Therapy Retrospective study with a 65% response rate among
adolescents between 13 and 18 years old
Paillère-Martinot et al. [39] 1990 Encephale Patients aged 15 to 19 years with different diagnoses achieved
88% of response rate after typical ECT application
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while adults had mainly affective disorders [35]. Mainten-
ance ECT in association with pharmacological treatment
presented good outcomes for refractory schizophrenia.
ECT sessions in a group with drug-resistant schizophrenia
resulted in an improvement in quality of life [27,32].
Side effects, risks, and complications of ECT use
In 1990, the APA Task Force on ECT cited no absolute
contraindications to ECT [38]. Although some studies
claim that even patients with severe cardiovascular con-
ditions or neurological diseases may benefit from this
therapy, guidelines still consider that more studies are
needed to allow ECT use in such medical conditions
[24,25]. Central nervous system tumors with high levels
of cerebrospinal fluid, active pneumonia, and recent
myocardial infarction are commonly considered relative
contraindications in adolescents [39].
After an ECT session, patients must have their vital
signs monitored for 1 to 2 h. Delayed seizures are infre-
quent but can occur until 48 h after the procedure,
representing a reason for monitoring patients in this
period [37].
Tardive or prolonged seizures and memory impair-
ment are adverse effects commonly associated to elec-
troconvulsive therapy [39]. The health care team must
be attentive to potential harmful effects of general
anesthesia [31]. Headache, nausea and vomiting, agita-
tion, and mental confusion are often reported as the
most common adverse effects of ECT [14].
Limitations of the retrieved studies
Finally, it is important to highlight the methodological
characteristics of the studies described in the present re-
view, as methodological differences hamper the compar-
ability and generalization of the results. The small samples
with which most studies dealt with [7,12,17,18,21,29,31,34],
although probably caused by ethical barriers concerning
experimental studies involving adolescents, reinforce the
importance of assessing the consistency of the results
found.
There were also other methodological limitations, such
as the absence of control groups [7,30]. Although au-
thors claim that these peculiarities do not affect the re-
sults, the generalization and reproducibility of findings
may be impaired.
Conclusions
The common-sense knowledge that ECT is a risky prac-
tice makes it the most controversial and polemic treat-
ment approach in psychiatry. However, even after the
development of psychopharmacology in the 1950s, ECT
maintains its relevance for psychiatry. Nowadays, ECT is
still considered a highly efficient option for treatment of
several psychiatric disorders, achieving high rates of re-
mission, with few and relatively benign adverse effects.
Research on the use of ECT in adolescents can be con-
sidered recent, since the first studies date from the
1980s. Despite of that, ECT is the treatment of choice
depending on diagnosis, severity of symptoms, and lack
of response to psychopharmacotherapy. The majority of
the studies in the scientific literature show the efficiency
of ECT use in adolescents and consider this approach
more efficient than psychopharmacotherapy isolated.
If ECT is performed in agreement with the guidelines,
risks are relatively low. In addition, an experienced staff
and adequate physical conditions can minimize the risk
of complications. Taking this into account, an important
area that requires further research is the development of
programs that successfully prepare health care profes-
sionals to deal with ECT in the clinical ambience, being
Table 2 Electroconvulsive therapy use in adolescents: main findings (Continued)
Side effects, risks, and complications of ECT for adolescents
Feliu et al. [17] 2008 Neuropsychiatric Disease
and Treatment
Relatively immediate and significant decreases in multiple areas
of memory following ECT, compared with pre-ECT levels of
functioning, including verbal memory for word lists, prose passages,
and visual memory of geometric designs
Datka et al. [21] 2007 Klinika Psychiatrii CM UJ. One day after first ECT, patient's working memory was slightly impaired.
ECT treatment affects working memory function only temporally
Prakash et al. [22] 2006 Journal of ECT ECT presents cognitive side effects especially in recent memory.
The post-ECT recovery of various components of cognition was more
rapid in patients using donepezil and compared with placebo
Cohen et al. [31] 2000 The American
Journal of Psychiatry
After a 3.5-year follow-up, patients who received ECT presented
similar memory functions to those of psychiatric controls. Poorer
cognitive performance is related with greater psychopathology,
not with the treatment
Ghazziudin et al. [32] 1999 Journal of Child
and Adolescent
Psychopharmacology
Comparison with pre-ECT and post-ECT tests resulted in significant
impairments of concentration and attention, verbal and visual
delayed recall, and verbal fluency. Second stage of post-ECT tests
(mean, 8.5 months after ECT) showed complete recovery and
return to pre-ECT functioning
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able to adequately conduct ECT procedures so as to stop
the deleterious effects of the psychopathologies.
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